Bailiang Li

机构：Personalis (United States) · ORCID：0000-0001-6729-219X

发表论文 67 篇 · 总被引 1750 次 · h-index 17

代表论文

• Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma (2025 · Nature Medicine · 被引 93)
• Longitudinal ultrasensitive ctDNA monitoring for high-resolution lung cancer risk prediction (2025 · Cell · 被引 25)
• Ultrasensitive ctDNA monitoring reveals early predictors of immunotherapy response in advanced cancer (2026 · npj Precision Oncology · 被引 5)
• Broad Utility of Ultrasensitive Analysis of ctDNA Dynamics across Solid Tumors Treated with Immunotherapy (2025 · Clinical Cancer Research · 被引 4)
• Abstract CT170: Neoadjuvant pembrolizumab stratified by tumor mutation burden in high-risk stage II-III dMMR/MSI colorectal cancer (NEOPRISM-CRC): Perioperative ultrasensitive ctDNA monitoring and tumor-infiltrating TCR repertoire for treatment response prediction (2026 · Cancer Research · 被引 1)
• Supplementary Figure 3 from Predictors of Immune Checkpoint Blockade Response in dMMR Colorectal Cancer Using an Integrated Immune-Enhanced Multiomics Platform (2026)